Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial Geriatrics Institute, Guangzhou, 510080, China.
Department of Nephrology, Blood Purification Center, Zhongshan City People's Hospital, Zhongshan, 528403, China.
BMC Nephrol. 2021 Nov 30;22(1):396. doi: 10.1186/s12882-021-02613-6.
Cardiovascular diseases (CVD) are the leading cause of death in patients with chronic kidney disease (CKD), and the risk of CVD increases with reductions in renal function. This study aims to investigate the potential roles of B lymphocyte populations in subclinical atherosclerosis (measured by intima-media thickness, IMT) and prognosis in elderly patients with moderate-to-severe CKD.
In this study, a total of 219 patients (143 moderate-to-severe CKD patients with stage 3-4 and 76 non-CKD controls) were recruited. B cell subsets: CD19(+)CD5(+) and CD19(+)CD5(-) B cells were analyzed by flow cytometry. Intima-media thickness (IMT) was measured by ultrasound. Correlations between the B cell subsets with IMT and clinical outcome was analyzed.
CKD patients showed increased IMT (P = 0.006). The level of CD19(+)CD5(+) and CD19(+)CD5(-) B cells were decreased in CKD patients. Correlation analysis showed that IMT was positively correlated with systolic blood pressure, protein/creatinine ratio and diabetes (P < 0.05), and were negatively correlated with CD19(+)CD5(+) and CD19(+)CD5(-) B lymphocytes (P < 0.05). Stepwise multiple regression analysis showed that CD19(+)CD5(-) B cells had a significant independent association with IMT (P < 0.05). IMT was increased in lower level of total CD19(+) B cells (≤ 0.06 × 10 /L) and CD19(+)CD5(-) B cells (≤ 0.05 × 10 /L) (P < 0.05). Kaplan-Meier analysis showed that patients with lower levels of CD19(+)CD5(+) and CD19(+)CD5(-) B cells exhibited worse survival (P < 0.05). Cox regression analysis showed that patients with lower CD19(+)CD5(+) and CD19(+)CD5(-) B cells counts have a higher risk of all-cause mortality (P < 0.05).
Our results showed that decreased CD19(+)CD5(+) and CD19(+)CD5(-) B lymphocytes were correlated with atherosclerosis and worse survival, which indicates that B lymphocytes might involve in atherosclerosis and associated the prognosis of elderly patients with moderate-to-severe CKD.
心血管疾病(CVD)是慢性肾脏病(CKD)患者死亡的主要原因,随着肾功能的下降,CVD 的风险增加。本研究旨在探讨亚临床动脉粥样硬化(通过内膜-中层厚度[IMT]测量)和预后中 B 淋巴细胞亚群在老年中-重度 CKD 患者中的潜在作用。
本研究共纳入 219 名患者(143 名中-重度 CKD 患者,分期 3-4 期和 76 名非 CKD 对照)。通过流式细胞术分析 B 细胞亚群:CD19(+)CD5(+)和 CD19(+)CD5(-)B 细胞。通过超声测量内膜-中层厚度(IMT)。分析 B 细胞亚群与 IMT 及临床结局的相关性。
CKD 患者的 IMT 增加(P=0.006)。CKD 患者的 CD19(+)CD5(+)和 CD19(+)CD5(-)B 细胞水平降低。相关性分析表明,IMT 与收缩压、蛋白/肌酐比和糖尿病呈正相关(P<0.05),与 CD19(+)CD5(+)和 CD19(+)CD5(-)B 淋巴细胞呈负相关(P<0.05)。逐步多元回归分析显示,CD19(+)CD5(-)B 细胞与 IMT 具有显著的独立相关性(P<0.05)。总 CD19(+)B 细胞(≤0.06×10 /L)和 CD19(+)CD5(-)B 细胞(≤0.05×10 /L)水平较低时,IMT 增加(P<0.05)。Kaplan-Meier 分析显示,CD19(+)CD5(+)和 CD19(+)CD5(-)B 细胞水平较低的患者生存状况较差(P<0.05)。Cox 回归分析显示,CD19(+)CD5(+)和 CD19(+)CD5(-)B 细胞计数较低的患者全因死亡率风险较高(P<0.05)。
我们的结果表明,CD19(+)CD5(+)和 CD19(+)CD5(-)B 淋巴细胞减少与动脉粥样硬化和较差的生存相关,这表明 B 淋巴细胞可能参与动脉粥样硬化,并与老年中-重度 CKD 患者的预后相关。